CDSCO advisory puts pharmacy dispensing practices under sharper scrutiny
India’s drug regulator has cautioned against self-medication with antibiotics and painkillers, linking misuse to chronic kidney disease risks. The advisory raises the need for stronger pharmacist counselling, prescription checks and consumer awareness across pharmacy retail.
What happened
Central Drugs Standard Control Organization (CDSCO) · India’s CDSCO warned against self-medication with antibiotics and painkillers, citing chronic kidney
Why this matters
Acquirers should prioritize pharmacy targets with auditable dispensing controls, pharmacist coverage and digital prescription workflows, as regulatory readiness becomes a more material diligence criterion.
What to watch
- CDSCO follow-up circulars, inspections, warning letters or revised Schedule H/H1 enforcement guidance.
- State drug-controller inspection drives and penalties for non-prescription antibiotic sales.
- Mandates or proposals for e-prescription verification, pharmacist presence or dispensing-record retention.
- Reported increases in chronic kidney disease awareness campaigns tied to analgesic misuse.
- Pharmacy-chain disclosures of compliance spending, pharmacist hiring or prescription-validation changes.
- Audit prescription-only medicine workflows, including antibiotic, NSAID and repeat-purchase controls.
- Increase licensed pharmacist coverage and document counselling for high-risk medicines.
- Deploy digital prescription capture, exception flags and audit trails across stores and delivery channels.
- Refresh consumer messaging on antibiotic resistance, painkiller misuse and kidney-risk warnings.
- Engage state drug-control authorities and industry bodies on implementation expectations.